Publications
Detailed Information
High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence dagger
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chun, J. | - |
dc.contributor.author | Kim, W. | - |
dc.contributor.author | Lee, K. L. | - |
dc.contributor.author | Kim, B. G. | - |
dc.contributor.author | Suh, K. -S. | - |
dc.contributor.author | Park, K. U. | - |
dc.contributor.author | Yoon, J. -H. | - |
dc.contributor.author | Lee, H. S. | - |
dc.contributor.author | Kim, Y. J. | - |
dc.contributor.author | Yi, N. -J. | - |
dc.date.accessioned | 2012-05-23T01:26:26Z | - |
dc.date.available | 2012-05-23T01:26:26Z | - |
dc.date.issued | 2010-07 | - |
dc.identifier.citation | AMERICAN JOURNAL OF TRANSPLANTATION; Vol.10 7; 1649-1659 | ko_KR |
dc.identifier.issn | 1600-6135 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76295 | - |
dc.description.abstract | Hepatitis B virus (HBV) recurrence following orthotopic liver transplantation (OLT) is generally preventable by prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine (LAM). However, HBV recurrence sometimes develops despite prophylaxis. This study assessed posttransplant outcomes and identified predictors of HBV recurrence. We analyzed the outcomes of 209 consecutive patients positive for hepatitis B surface antigen who underwent OLT, who received either combination prophylaxis with HBIG and LAM (89.0%) or HBIG monoprophylaxis (11.0%). The median follow-up was 36.8 months (range, 1.0-84.4). Posttransplant HBV recurrence occurred in 22 patients (10.5%), including 13 patients with drug-resistant mutations. HBV recurrence was observed in six patients after hepatocellular carcinoma (HCC) recurrence. Independent predictors of HBV recurrence were recurrent HCC (p < 0.001), LAM therapy > 1.5 years (p = 0.001) and high HBV DNA titers (>= 105 copies/mL) at OLT (p = 0.036). In conclusion, high viremia at OLT and prolonged exposure to LAM should be further stressed as main predictors of HBV recurrence. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WILEY-BLACKWELL | ko_KR |
dc.subject | Hepatocellular carcinoma | ko_KR |
dc.subject | liver transplantation | ko_KR |
dc.subject | mutation | ko_KR |
dc.subject | recurrence | ko_KR |
dc.subject | viral hepatitis | ko_KR |
dc.title | High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence dagger | ko_KR |
dc.type | Article | ko_KR |
dc.identifier.doi | 10.1111/j.1600-6143.2010.03162.x | - |
dc.citation.journaltitle | AMERICAN JOURNAL OF TRANSPLANTATION | - |
dc.description.citedreference | Faria LC, 2008, GASTROENTEROLOGY, V134, P1890, DOI 10.1053/j.gastro.2008.02.064 | - |
dc.description.citedreference | FARIA LC, 2008, GASTROENTEROLOGY, V134, P2155 | - |
dc.description.citedreference | Wong SN, 2007, LIVER TRANSPLANT, V13, P334, DOI 10.1002/lt.20959 | - |
dc.description.citedreference | Yi NJ, 2007, LIVER TRANSPLANT, V13, P451, DOI 10.1002/lt.21043 | - |
dc.description.citedreference | Woo HY, 2007, ANTIVIR THER, V12, P7 | - |
dc.description.citedreference | Lo CM, 2005, AM J TRANSPLANT, V5, P1893, DOI 10.1111/j.1600-6143.2005.00952.x | - |
dc.description.citedreference | Terrault N, 2005, LIVER TRANSPLANT, V11, P716, DOI 10.1002/lt.20492 | - |
dc.description.citedreference | Marzano A, 2005, LIVER TRANSPLANT, V11, P402, DOI 10.1002/lt.20402 | - |
dc.description.citedreference | Song BC, 2005, INTERVIROLOGY, V48, P133, DOI 10.1159/000081740 | - |
dc.description.citedreference | Neff GW, 2004, LIVER TRANSPLANT, V10, P1372, DOI 10.1002/lt.20277 | - |
dc.description.citedreference | Kim WR, 2004, LIVER TRANSPLANT, V10, P968, DOI 10.1002/lt.20217 | - |
dc.description.citedreference | Hong SP, 2004, J HEPATOL, V40, P837, DOI 10.1016/j.jhep.2004.01.006 | - |
dc.description.citedreference | Roche B, 2003, HEPATOLOGY, V38, P86, DOI 10.1053/jhep.2003.50294 | - |
dc.description.citedreference | Locarnini S, 2003, SEMIN LIVER DIS, V23, P5 | - |
dc.description.citedreference | Yao FY, 2002, LIVER TRANSPLANT, V8, P765, DOI 10.1053/jlts.2002.34892 | - |
dc.description.citedreference | Steinmuller T, 2002, HEPATOLOGY, V35, P1528, DOI 10.1053/jhep.2002.33681 | - |
dc.description.citedreference | Bock CT, 2002, GASTROENTEROLOGY, V122, P264, DOI 10.1053/gast.2002.31015 | - |
dc.description.citedreference | Rosenau J, 2001, J HEPATOL, V34, P895 | - |
dc.description.citedreference | Marzano A, 2001, J HEPATOL, V34, P903 | - |
dc.description.citedreference | Perrillo RP, 2001, HEPATOLOGY, V33, P424, DOI 10.1053/jhep.2001.21554 | - |
dc.description.citedreference | Han SHB, 2000, LIVER TRANSPLANT, V6, P741 | - |
dc.description.citedreference | Mutimer D, 2000, TRANSPLANTATION, V70, P809 | - |
dc.description.citedreference | Angus PW, 2000, LIVER TRANSPLANT, V6, P429 | - |
dc.description.citedreference | Malkan G, 2000, TRANSPLANTATION, V69, P1403 | - |
dc.description.citedreference | Terrault NA, 1998, HEPATOLOGY, V28, P555 | - |
dc.description.citedreference | Trautwein C, 1996, HEPATOLOGY, V24, P482 | - |
dc.description.citedreference | WONG PYN, 1995, AM J GASTROENTEROL, V90, P29 | - |
dc.description.citedreference | SAMUEL D, 1993, NEW ENGL J MED, V329, P1842 | - |
dc.description.citedreference | OGRADY JG, 1992, J HEPATOL, V14, P104 | - |
dc.description.citedreference | SAMUEL D, 1991, LANCET, V337, P813 | - |
dc.description.citedreference | TODO S, 1991, HEPATOLOGY, V13, P619 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.